netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Apixaban found 13 matches
Open monograph to display formulary status BNF Category
  Apixaban Cardiovascular system - Oral anticoagulants - 02.08.02
  Andexanet alfa  (Ondexxya®) Cardiovascular system - Oral anticoagulants - 02.08.02
  Dabigatran Cardiovascular system - Oral anticoagulants - 02.08.02
  Edoxaban Cardiovascular system - Oral anticoagulants - 02.08.02
  Rivaroxaban Cardiovascular system - Oral anticoagulants - 02.08.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section MHRA Drug Safety Update Dec 2014: New oral anticoagulants apixaban (Eliquis▼), dabigatran (Pradaxa) and rivaroxaban (Xarelto▼) (02.08.02)
link in drug section NICE TA245: Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (02.08.02)
link in drug section NICE TA275: Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (02.08.02)
link in drug section NICE TA341: Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (02.08.02)
link in drug section NICE TA697: Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (02.08.02)


 
netFormulary